Cargando…
Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018699/ https://www.ncbi.nlm.nih.gov/pubmed/35440080 http://dx.doi.org/10.1038/s41419-022-04705-z |
| _version_ | 1784689079318740992 |
|---|---|
| author | Guo, Yangyang Zhu, Hengyue Xiao, Yanyi Guo, Hangcheng Lin, Miaomiao Yuan, Ziwei Yang, Xuejia Huang, Youze Zhang, Qiyu Bai, Yongheng |
| author_facet | Guo, Yangyang Zhu, Hengyue Xiao, Yanyi Guo, Hangcheng Lin, Miaomiao Yuan, Ziwei Yang, Xuejia Huang, Youze Zhang, Qiyu Bai, Yongheng |
| author_sort | Guo, Yangyang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9018699 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90186992022-04-28 Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression Guo, Yangyang Zhu, Hengyue Xiao, Yanyi Guo, Hangcheng Lin, Miaomiao Yuan, Ziwei Yang, Xuejia Huang, Youze Zhang, Qiyu Bai, Yongheng Cell Death Dis Correction Nature Publishing Group UK 2022-04-19 /pmc/articles/PMC9018699/ /pubmed/35440080 http://dx.doi.org/10.1038/s41419-022-04705-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Guo, Yangyang Zhu, Hengyue Xiao, Yanyi Guo, Hangcheng Lin, Miaomiao Yuan, Ziwei Yang, Xuejia Huang, Youze Zhang, Qiyu Bai, Yongheng Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title | Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title_full | Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title_fullStr | Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title_full_unstemmed | Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title_short | Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| title_sort | correction: the anthelmintic drug niclosamide induces gsk-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018699/ https://www.ncbi.nlm.nih.gov/pubmed/35440080 http://dx.doi.org/10.1038/s41419-022-04705-z |
| work_keys_str_mv | AT guoyangyang correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT zhuhengyue correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT xiaoyanyi correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT guohangcheng correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT linmiaomiao correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT yuanziwei correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT yangxuejia correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT huangyouze correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT zhangqiyu correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression AT baiyongheng correctiontheanthelminticdrugniclosamideinducesgskbmediatedbcatenindegradationtopotentiategemcitabineactivityreduceimmuneevasionabilityandsuppresspancreaticcancerprogression |